(MYCF) SPDR SSGA My2026 Corporate - Ratings and Ratios
Corporate Bonds, 2026 Maturity, Embedded Options
Description: MYCF SPDR SSGA My2026 Corporate
The SSGA My2026 Corporate Bond ETF is a targeted maturity ETF that focuses on investing at least 80% of its net assets in corporate bonds with maturities in 2026, potentially including bonds with embedded issuer call options that fall within that year. This non-diversified fund is managed by SSGA Funds Management, Inc. and offers a unique investment strategy centered around a specific maturity date.
Given its investment strategy, the funds performance is closely tied to the corporate bond market, particularly for bonds maturing in 2026. The funds holdings are likely to be influenced by the overall credit quality of the issuers, prevailing interest rates, and market sentiment towards corporate debt. As a targeted maturity fund, it is designed to provide investors with a predictable income stream and return of principal at maturity, assuming the issuers of the bonds held by the fund do not default.
Analyzing the
Forecasting the ETFs performance based on the available data, we can anticipate that as long as the corporate bond market remains stable and interest rates do not fluctuate wildly, the fund should continue on its current trajectory. The proximity to its 52-week high of $25.06 and the relatively low volatility (as indicated by ATR) suggest that the ETF might continue to hover around its current price or potentially edge closer to its 52-week high. However, any significant changes in interest rates or corporate bond market sentiment could impact this forecast. Therefore, it is crucial for investors to monitor these factors closely.
Investors considering MYCF should be aware of the credit risk associated with corporate bonds and the potential impact of interest rate changes on the funds NAV. The funds non-diversified nature means that it may be more susceptible to significant losses if any of the issuers of its holdings default. Nonetheless, for investors seeking exposure to corporate bonds maturing in 2026, MYCF presents a targeted investment opportunity that could help in managing interest rate risk and potentially benefiting from the yield offered by corporate bonds.
Additional Sources for MYCF ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
MYCF ETF Overview
Market Cap in USD | 34m |
Category | Target Maturity |
IPO / Inception | 2024-09-23 |
MYCF ETF Ratings
Growth Rating | 45.7 |
Fundamental | - |
Dividend Rating | 56.5 |
Rel. Strength | -9.43 |
Analysts | - |
Fair Price Momentum | 24.48 USD |
Fair Price DCF | - |
MYCF Dividends
Dividend Yield 12m | 3.48% |
Yield on Cost 5y | 3.56% |
Annual Growth 5y | 36.17% |
Payout Consistency | 100.0% |
Payout Ratio | % |
MYCF Growth Ratios
Growth Correlation 3m | 98% |
Growth Correlation 12m | 99.5% |
Growth Correlation 5y | 99.5% |
CAGR 5y | 3.51% |
CAGR/Max DD 5y | 5.87 |
Sharpe Ratio 12m | -0.22 |
Alpha | -0.73 |
Beta | 0.004 |
Volatility | 0.97% |
Current Volume | 55.5k |
Average Volume 20d | 3.2k |
Stop Loss | 24.2 (-3.4%) |
As of July 09, 2025, the stock is trading at USD 25.04 with a total of 55,475 shares traded.
Over the past week, the price has changed by +0.10%, over one month by +0.56%, over three months by +1.36% and over the past year by +3.51%.
Partly, yes. Based on ValueRay´s Analyses, SPDR SSGA My2026 Corporate (NASDAQ:MYCF) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 45.73 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MYCF is around 24.48 USD . This means that MYCF is currently overvalued and has a potential downside of -2.24%.
SPDR SSGA My2026 Corporate has no consensus analysts rating.
According to our own proprietary Forecast Model, MYCF SPDR SSGA My2026 Corporate will be worth about 26.4 in July 2026. The stock is currently trading at 25.04. This means that the stock has a potential upside of +5.59%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 26.4 | 5.6% |